Quicker drug approvals on the way for Europe

Article Abstract:

In mid July the European Commission proposed shortening the drug approval process in Europe to help Europe's drug companies remain competitive. The proposals include at least 15 points such as a single approval process for all member countries.

European Union

---

User-fee bill passes U.S. senate, but legislative hurdles remain

Article Abstract:

The U.S. Senate renewed the user fee bill for drug reviews however, there are legislative hindrances from the House members in reauthorization of the bill and demands for funding from increased direct appropriations.

United States, Public Finance Activities, Legal issues & crime, Government regulation, Legal/Government Regulation, Metabolic Agents NEC, User Taxes, Metabolic Agents, Usage, Laws, regulations and rules, User fees

---

British Biotech redefines itself

Article Abstract:

British Biotech changes its focus from developing matrix metalloproteinase inhibitors to creating antibiotics. The company reduced its losses by 36 percent in 2001.

United Kingdom, Sales, profits & dividends, Antiinfective Preparations, Anticancer Drugs, Anti-infective agents, Antineoplastic agents, British Biotech PLC

Similar abstracts:

• Abstracts: Staying ahead of the retail game. Kiosks - it's all about connectivity
• Abstracts: Panama Builds on Reform. ROI is here, but where's the new revenue? Biotech charts technology recovery
• Abstracts: Brokering an online future. Online broking battle hots up. Competition raises brokers' game
• Abstracts: Prospects for additional tax legislation in 2001. Year-end tax legislation. What is new for the 2000 tax return filing season?
• Abstracts: Banking on the Euro: Changes and Challenges

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.